In a recent LinkedIn post, Melissa Perri explores the critical challenges and strategic advantages of building Artificial Intelligence within regulated industries. Perri emphasizes that unlike typical tech development, which often follows a “move fast and break things” mantra, AI in sectors like healthcare and finance demands a far more deliberate and cautious approach.
Perri highlights the significant differences in stakes:
“In healthcare, finance, and other regulated sectors, AI hallucinations aren’t just bugs, they’re compliance violations. When your product operates in environments where mistakes trigger audits, lawsuits, or regulatory action, the stakes fundamentally change how you build.”
The insights shared by Perri stem from a recent episode of her “Product Thinking with Melissa Perri” podcast, which featured guests with direct experience in these complex environments: Dr. Maryam Ashoori from IBM Watson X, Magda Armbruster from Natural Cycles, and Jessica Hall from Just Eat Takeaway.com. The discussion focused on how these leaders are successfully developing AI while adhering to strict regulatory frameworks.
Integrating Compliance for Clarity and Advantage
A key takeaway from the discussion, as highlighted by Perri, is the proactive role of regulatory teams. Instead of viewing compliance as an afterthought or a hurdle, Perri relays that early and continuous engagement with regulatory experts can be a significant asset.
Designing with Guardrails
Perri relays Magda Armbruster’s perspective:
“bringing regulatory teams into product development early doesn’t slow you down, it creates clarity. Instead of retrofitting compliance, you’re designing with guardrails from day one.”
This approach, Perri explains, shifts the paradigm from remediation to proactive design. By embedding compliance considerations from the outset, development teams can build AI systems that are inherently safer and more aligned with industry standards. This contrasts sharply with traditional methods where compliance might be addressed only as a final step, often leading to costly revisions and delays.
Human Oversight and Strategic Differentiation
Further elaborating on the practicalities of AI development in regulated spaces, Perri discusses the necessity of human intervention at crucial junctures. As Perri notes, quoting Dr. Maryam Ashoori:
“Maryam explained how this translates to AI agents that need human oversight at critical decision points.”
This emphasis on human oversight is crucial for mitigating risks associated with AI, particularly in scenarios where errors could have severe consequences. Perri also points to Jessica Hall’s contribution, illustrating how companies can strategically balance these regulatory constraints with business objectives like unit economics and long-term capability building.
Turning Regulation into a Competitive Moat
Perri concludes her post by framing regulatory adherence not as a burden, but as a potential source of competitive advantage. Companies that excel in this area, she argues, can leverage their robust processes and thoughtful AI deployment to build a strong market position.
“The companies that get this right are turning regulatory excellence into competitive advantage. Clear processes, embedded compliance, and thoughtful AI deployment become your moat.”
Perri challenges businesses to consider their own approach, asking, “Are you treating regulation as a roadblock or as a strategic differentiator in your AI strategy?” This framing underscores the evolving landscape where compliance is increasingly becoming a key factor in successful AI product development within sensitive industries.
📝 About This Content
This article is based on insights shared by Melissa Perri on LinkedIn.
📅 Originally posted on January 28, 2026 | View original post on LinkedIn →